Transitional Cell Cancer of the Renal Pelvis and Ureter Completed Phase 1 Trials for Lapatinib (DB01259)

Also known as: Transitional Cell Cancer of Renal Pelvis and Ureter / Transitional Cell Tumor / Transitional cell carcinoma of upper urinary tract (disorder) / Transitional cell cancer of the renal pelvis and ureter NOS / Renal pelvis and ureter transitional cell cancer NOS / Renal pelvis and ureteric cancer NOS transitional cell / Renal pelvis and ureteral cancer transitional cell NOS / Renal pelvis and ureteric cancer transitional cell NOS

IndicationStatusPhase
DBCOND0028512 (Transitional Cell Cancer of the Renal Pelvis and Ureter)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00623064Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial CancerTreatment